Pectin/chitosan/Eudragit® RS mixed-film coating for bimodal drug delivery from theophylline pellets: Preparation and evaluation

Acta Pharmaceutica

Volumn 56, Issue 3, 2006, Pages 299-310

  Ghaffari, Alireza ^a,c   Oskoui, Mahvash ^b   Helali, Kamran ^a   Bayati, Khosrow ^a   Rafiee Tehrani, Morteza ^c  

^a Shahre Darou Pharmaceutical Co   (Iran)

^b PASTEUR INSTITUTE OF IRAN   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Bimodal drug delivery; Burst release; Chitosan; Eudragit RS; Mixed film coating; Pectin; Pellet

Indexed keywords

CHITOSAN; EUDRAGIT; MICROCRYSTALLINE CELLULOSE; PECTIN; THEOPHYLLINE;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; FILM COATING; GASTROINTESTINAL TRACT; HUMAN; PH; SCANNING ELECTRON MICROSCOPY; SMALL INTESTINE; VISCOSITY;

EID: 33748867890     PISSN: 13300075     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. N. Follonier and E. Doelker, Biopharmaceutical comparison of oral multiple-unit and single-unit sustained-release dosage forms, STP Pharma Sci. 2 (1992) 141-155.
2. st ed., Marcel Dekker, New York 1994, pp. 307-332.
3. th Pharmaceutical Technology Conference, Athens, April 15-17,1997, Pharmaceutical Technology, Athens 1997, Vol. 2, pp. 38-45.
4. B. Lemmer, Circadian rhythms and drug delivery, J. Control. Rel. 16 (1991) 63-74.
5. G. S. Macleod, J. T. Fell and J. H. Collett, An in vitro investigation into the potential for bimodal drug release from pectin/chitosan/HPMC-coated tablets, Int. J. Pharm. 188 (1999) 11-18.
6. M. Ashford, J. T. Fell, D. Attwood, H. Sharma and P. Woodhead, Studies on pectin formulations for colonic drug delivery, J. Control. Rel. 30 (1994) 225-232.
7. R. Semdé, K. Amighi, D. Pierre, M. J. Devleeschouwer and A. J. Moës, Leaching of pectin from mixed pectin/insoluble polymer films intended for colonic drug delivery, Int. J. Pharm. 174 (1998) 233-241.
8. A. H. Staib, D. Loew, S. Harder, E. H. Graul and R. Pfab, Measurement of theophylline absorption from different regions of the gastro-intestinal tract using a remote controlled drug delivery device, Eur. J. Clin. Pharmacol. 30 (1986) 691-697.
9. nd ed., Marcel Dekker, New York 1997, pp. 101-176.
10. United States Pharmacopoeia 28, United States Pharmacopoeial Convention, Rockville 2005, pp. 1896-1899.
11. G. S. Macleod, J. H. Collett and J. T. Fell, The potential use of mixed films of pectin, chitosan and HPMC for bimodal drug release, J. Control. Rel. 58 (1999) 303-310.
12. Z. Wakerly, J. T. Fell, D. Attwood and D. A. Parkins, In vitro evaluation of pectin-based colonic drug delivery systems, Int. J. Pharm. 129 (1996) 73-77.
13. st ed., Harwood Academic Publishers, Amsterdam 1997, pp. 451-471.
14. Pectinex® Ultra SP-L, Product Sheet (B 302d-GB), Novo Nordisk Ferment Ltd., Dittingen 1997.
15. A. Göpferich and R. Langer, Modeling monomer release from bioerodible polymers, J. Control. Rel. 33 (1995) 55-69.
16. J. G. Wagner, Interpretation of percent dissolved-time plots derived from in vitro testing of conventional tablets and capsules, J. Pharm. Sci. 58 (1969) 1253-1257.
17. T. Higuchi, Mechanism of sustained action medication, J. Pharm. Sci. 52 (1963) 1145-1149.
18. R. W. Korsmeyer, R. Gurny, E. Doelker, P. Buri and N. A. Peppas, Mechanism of solute release from hydrophilic polymers, Int. J. Pharm. 15 (1983) 25-35.
19. N. A. Peppas, Analysis of Fickian and non Fickian drug release from polymers, Pharm. Acta Helv. 60 (1985) 110-111.
20. R. Semdé, K. Amighi, D. Pierre, M. J. Devleeschouwer and A. J. Moës, Effect of pectinolytic enzymes on the theophylline release from pellets coated with water insoluble polymers containing pectin HM or calcium pectinate, Int. J. Pharm. 197 (2000) 169-179.